Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

 

Cancer genetics, epigenetics, cancer vaccines.

 

Sidney Kimmel Comprehensive Cancer Center, part of the Johns Hopkins family of medical facilities, received U.S. News & World Report’s best grade for patient survival, use of advanced technology, nurse-to-patient ratio, and availability of key services. The center strives to constantly improve therapeutic options for patients and give them access to the most innovative and advanced therapies possible. The center is known as a “cancer research powerhouse” — industry analyst Thomson Scientific reports findings from this institution are the most frequently cited in the works of other researchers. Kimmel discovered that cancer is a genetic disease, drew up the first map of a cancer genome, developed the first therapeutic cancer vaccines, and used molecular data to devise broad-based cancer screening tests, monitor patients for cancer progression and recurrence, and determine surgical margins. Research scientists and clinicians at Kimmel work closely on deciphering the mechanisms of cancer initiation and progression. New drugs and treatments developed in Kimmel laboratories tend to quickly find their way into the clinical setting.